A rapidly changing understanding of COPD: World COPD Day from the COPD Foundation.


Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 11 2021
Historique:
pubmed: 7 10 2021
medline: 18 11 2021
entrez: 6 10 2021
Statut: ppublish

Résumé

World COPD Day raises awareness about chronic obstructive pulmonary disease (COPD). COPD accounts for over 150,000 US deaths per year. A major challenge is that COPD receives only a fraction of the research funding provided to other major diseases. Control of COPD is dependent on developing new approaches to diagnose the disease earlier with a recognition of either pre-COPD or established COPD based on symptoms, lung structural change and/or loss of lung function that occurs before meeting long established criteria for a population-based definition of obstruction. Optimization of current therapies improves lung function, exercise capacity, quality of life, and survival. New pathways of disease progression are being identified creating new opportunities for development of therapies that could stop or cure this disease.

Identifiants

pubmed: 34612086
doi: 10.1152/ajplung.00400.2021
doi:

Types de publication

Editorial Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

L983-L987

Commentaires et corrections

Type : CommentIn
Type : CommentOn

Auteurs

Byron M Thomashow (BM)

COPD Foundation, Miami, Florida.
Department of Medicine, Columbia University, New York, New York.

David M Mannino (DM)

COPD Foundation, Miami, Florida.
Department of Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.

Ruth Tal-Singer (R)

COPD Foundation, Miami, Florida.

James D Crapo (JD)

COPD Foundation, Miami, Florida.
Department of Medicine, National Jewish Health, Denver, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH